Pharma & Healthcare
Global Pertussis Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 297735
- Pages: 123
- Figures: 127
- Views: 37
In 2024, the global market size of Pertussis Vaccine was estimated to be worth US$ 5555 million and is forecast to reach approximately US$ 7043 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.
The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pertussis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Segment by Type
Whole-cell Vaccines
Acellular Vaccines
Segment by Application
12 Months Below
12 Months Above
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pertussis Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pertussis Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.
The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pertussis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Segment by Type
Whole-cell Vaccines
Acellular Vaccines
Segment by Application
12 Months Below
12 Months Above
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pertussis Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pertussis Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Pertussis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pertussis Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Whole-cell Vaccines
1.2.3 Acellular Vaccines
1.3 Market by Application
1.3.1 Global Pertussis Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pertussis Vaccine Market Size Estimates and Forecasts
2.1.1 Global Pertussis Vaccine Revenue 2020-2031
2.1.2 Global Pertussis Vaccine Sales 2020-2031
2.2 Pertussis Vaccine Market Size by Region: 2024 Versus 2031
2.3 Pertussis Vaccine Sales by Region (2020-2031)
2.3.1 Global Pertussis Vaccine Sales by Region: 2020-2025
2.3.2 Global Pertussis Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Pertussis Vaccine Sales Market Share by Region (2020-2031)
2.4 Pertussis Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Pertussis Vaccine Revenue by Region: 2020-2025
2.4.2 Global Pertussis Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Pertussis Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Pertussis Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Pertussis Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Pertussis Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Pertussis Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Pertussis Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Pertussis Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Pertussis Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Pertussis Vaccine Sales by Application (2020-2031)
3.2.1.1 Global Pertussis Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global Pertussis Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global Pertussis Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global Pertussis Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global Pertussis Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 Pertussis Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Whole-cell Vaccines of Pertussis Vaccine Revenue Market Share by Application
3.3.2 Acellular Vaccines of Pertussis Vaccine Revenue Market Share by Application
4 Global Pertussis Vaccine by Manufacturers
4.1 Global Top Pertussis Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Pertussis Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Pertussis Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Pertussis Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Pertussis Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Pertussis Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Pertussis Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Pertussis Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Pertussis Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Pertussis Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Pertussis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Pertussis Vaccine Market
4.5.3 Manufacturers Pertussis Vaccine Product Type and Application
4.5.4 Whole-cell Vaccines Market Sales of Pertussis Vaccine by Manufacturer
4.5.5 Acellular Vaccines Market Sales of Pertussis Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sanofi Pasteur
5.1.1 Sanofi Pasteur Company Information
5.1.2 Sanofi Pasteur Description, Business Overview
5.1.3 Sanofi Pasteur Pertussis Vaccine Products Offered
5.1.4 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Sanofi Pasteur Pertussis Vaccine Sales by Product in 2024
5.1.6 Sanofi Pasteur Pertussis Vaccine Sales by Application in 2024
5.1.7 Sanofi Pasteur Pertussis Vaccine Sales by Geographic Area in 2024
5.1.8 Sanofi Pasteur Recent Developments
5.2 GSK
5.2.1 GSK Company Information
5.2.2 GSK Description, Business Overview
5.2.3 GSK Pertussis Vaccine Products Offered
5.2.4 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GSK Pertussis Vaccine Sales by Product in 2024
5.2.6 GSK Pertussis Vaccine Sales by Application in 2024
5.2.7 GSK Pertussis Vaccine Sales by Geographic Area in 2024
5.2.8 GSK Recent Developments
5.3 Mitsubishi Tanabe Pharma
5.3.1 Mitsubishi Tanabe Pharma Company Information
5.3.2 Mitsubishi Tanabe Pharma Description, Business Overview
5.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered
5.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales by Product in 2024
5.3.6 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales by Application in 2024
5.3.7 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales by Geographic Area in 2024
5.3.8 Mitsubishi Tanabe Pharma Recent Developments
5.4 Wuhan Institute of Biological Products
5.4.1 Wuhan Institute of Biological Products Company Information
5.4.2 Wuhan Institute of Biological Products Description, Business Overview
5.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered
5.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Wuhan Institute of Biological Products Pertussis Vaccine Sales by Product in 2024
5.4.6 Wuhan Institute of Biological Products Pertussis Vaccine Sales by Application in 2024
5.4.7 Wuhan Institute of Biological Products Pertussis Vaccine Sales by Geographic Area in 2024
5.4.8 Wuhan Institute of Biological Products Recent Developments
5.5 Walvax Biotechnology
5.5.1 Walvax Biotechnology Company Information
5.5.2 Walvax Biotechnology Description, Business Overview
5.5.3 Walvax Biotechnology Pertussis Vaccine Products Offered
5.5.4 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Walvax Biotechnology Pertussis Vaccine Sales by Product in 2024
5.5.6 Walvax Biotechnology Pertussis Vaccine Sales by Application in 2024
5.5.7 Walvax Biotechnology Pertussis Vaccine Sales by Geographic Area in 2024
5.5.8 Walvax Biotechnology Recent Developments
5.6 Minhai Biotechnology
5.6.1 Minhai Biotechnology Company Information
5.6.2 Minhai Biotechnology Description, Business Overview
5.6.3 Minhai Biotechnology Pertussis Vaccine Products Offered
5.6.4 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Minhai Biotechnology Pertussis Vaccine Sales by Product in 2024
5.6.6 Minhai Biotechnology Pertussis Vaccine Sales by Application in 2024
5.6.7 Minhai Biotechnology Pertussis Vaccine Sales by Geographic Area in 2024
5.6.8 Minhai Biotechnology Recent Developments
5.7 KM Biologics
5.7.1 KM Biologics Company Information
5.7.2 KM Biologics Description, Business Overview
5.7.3 KM Biologics Pertussis Vaccine Products Offered
5.7.4 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 KM Biologics Pertussis Vaccine Sales by Product in 2024
5.7.6 KM Biologics Pertussis Vaccine Sales by Application in 2024
5.7.7 KM Biologics Pertussis Vaccine Sales by Geographic Area in 2024
5.7.8 KM Biologics Recent Developments
5.8 Chengdu Institute of Biological Products
5.8.1 Chengdu Institute of Biological Products Company Information
5.8.2 Chengdu Institute of Biological Products Description, Business Overview
5.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Products Offered
5.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Chengdu Institute of Biological Products Pertussis Vaccine Sales by Product in 2024
5.8.6 Chengdu Institute of Biological Products Pertussis Vaccine Sales by Application in 2024
5.8.7 Chengdu Institute of Biological Products Pertussis Vaccine Sales by Geographic Area in 2024
5.8.8 Chengdu Institute of Biological Products Recent Developments
6 North America
6.1 North America Pertussis Vaccine Market Size YoY Growth 2020-2031
6.2 North America Pertussis Vaccine Market Facts & Figures by Country
6.2.1 North America Pertussis Vaccine Sales by Country (2020-2031)
6.2.2 North America Pertussis Vaccine Revenue by Country (2020-2031)
6.3 North America Pertussis Vaccine Sales by Type (2020-2025)
6.4 North America Pertussis Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Pertussis Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Pertussis Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Pertussis Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Pertussis Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Pertussis Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Pertussis Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe Pertussis Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Pertussis Vaccine Market Facts & Figures by Country
8.2.1 Europe Pertussis Vaccine Sales by Country (2020-2031)
8.2.2 Europe Pertussis Vaccine Revenue by Country (2020-2031)
8.3 Europe Pertussis Vaccine Sales by Type (2020-2025)
8.4 Europe Pertussis Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Pertussis Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Pertussis Vaccine Market Facts & Figures by Country
9.2.1 Latin America Pertussis Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Pertussis Vaccine Revenue by Country (2020-2031)
9.3 Latin America Pertussis Vaccine Sales by Type (2020-2025)
9.4 Latin America Pertussis Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Pertussis Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Pertussis Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Pertussis Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Pertussis Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Pertussis Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Pertussis Vaccine Supply Chain Analysis
11.2 Pertussis Vaccine Key Raw Materials and Upstream Suppliers
11.3 Pertussis Vaccine Clients Analysis
11.4 Pertussis Vaccine Sales Channel and Sales Model Analysis
11.4.1 Pertussis Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Pertussis Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Pertussis Vaccine Distributors
12 Pertussis Vaccine Market Dynamics
12.1 Pertussis Vaccine Industry Trends
12.2 Pertussis Vaccine Market Drivers
12.3 Pertussis Vaccine Market Challenges
12.4 Pertussis Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Pertussis Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pertussis Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Whole-cell Vaccines
1.2.3 Acellular Vaccines
1.3 Market by Application
1.3.1 Global Pertussis Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pertussis Vaccine Market Size Estimates and Forecasts
2.1.1 Global Pertussis Vaccine Revenue 2020-2031
2.1.2 Global Pertussis Vaccine Sales 2020-2031
2.2 Pertussis Vaccine Market Size by Region: 2024 Versus 2031
2.3 Pertussis Vaccine Sales by Region (2020-2031)
2.3.1 Global Pertussis Vaccine Sales by Region: 2020-2025
2.3.2 Global Pertussis Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Pertussis Vaccine Sales Market Share by Region (2020-2031)
2.4 Pertussis Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Pertussis Vaccine Revenue by Region: 2020-2025
2.4.2 Global Pertussis Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Pertussis Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Pertussis Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Pertussis Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Pertussis Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Pertussis Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Pertussis Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Pertussis Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Pertussis Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Pertussis Vaccine Sales by Application (2020-2031)
3.2.1.1 Global Pertussis Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global Pertussis Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global Pertussis Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global Pertussis Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global Pertussis Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 Pertussis Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Whole-cell Vaccines of Pertussis Vaccine Revenue Market Share by Application
3.3.2 Acellular Vaccines of Pertussis Vaccine Revenue Market Share by Application
4 Global Pertussis Vaccine by Manufacturers
4.1 Global Top Pertussis Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Pertussis Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Pertussis Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Pertussis Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Pertussis Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Pertussis Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Pertussis Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Pertussis Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Pertussis Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Pertussis Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Pertussis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Pertussis Vaccine Market
4.5.3 Manufacturers Pertussis Vaccine Product Type and Application
4.5.4 Whole-cell Vaccines Market Sales of Pertussis Vaccine by Manufacturer
4.5.5 Acellular Vaccines Market Sales of Pertussis Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sanofi Pasteur
5.1.1 Sanofi Pasteur Company Information
5.1.2 Sanofi Pasteur Description, Business Overview
5.1.3 Sanofi Pasteur Pertussis Vaccine Products Offered
5.1.4 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Sanofi Pasteur Pertussis Vaccine Sales by Product in 2024
5.1.6 Sanofi Pasteur Pertussis Vaccine Sales by Application in 2024
5.1.7 Sanofi Pasteur Pertussis Vaccine Sales by Geographic Area in 2024
5.1.8 Sanofi Pasteur Recent Developments
5.2 GSK
5.2.1 GSK Company Information
5.2.2 GSK Description, Business Overview
5.2.3 GSK Pertussis Vaccine Products Offered
5.2.4 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GSK Pertussis Vaccine Sales by Product in 2024
5.2.6 GSK Pertussis Vaccine Sales by Application in 2024
5.2.7 GSK Pertussis Vaccine Sales by Geographic Area in 2024
5.2.8 GSK Recent Developments
5.3 Mitsubishi Tanabe Pharma
5.3.1 Mitsubishi Tanabe Pharma Company Information
5.3.2 Mitsubishi Tanabe Pharma Description, Business Overview
5.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Products Offered
5.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales by Product in 2024
5.3.6 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales by Application in 2024
5.3.7 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales by Geographic Area in 2024
5.3.8 Mitsubishi Tanabe Pharma Recent Developments
5.4 Wuhan Institute of Biological Products
5.4.1 Wuhan Institute of Biological Products Company Information
5.4.2 Wuhan Institute of Biological Products Description, Business Overview
5.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Products Offered
5.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Wuhan Institute of Biological Products Pertussis Vaccine Sales by Product in 2024
5.4.6 Wuhan Institute of Biological Products Pertussis Vaccine Sales by Application in 2024
5.4.7 Wuhan Institute of Biological Products Pertussis Vaccine Sales by Geographic Area in 2024
5.4.8 Wuhan Institute of Biological Products Recent Developments
5.5 Walvax Biotechnology
5.5.1 Walvax Biotechnology Company Information
5.5.2 Walvax Biotechnology Description, Business Overview
5.5.3 Walvax Biotechnology Pertussis Vaccine Products Offered
5.5.4 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Walvax Biotechnology Pertussis Vaccine Sales by Product in 2024
5.5.6 Walvax Biotechnology Pertussis Vaccine Sales by Application in 2024
5.5.7 Walvax Biotechnology Pertussis Vaccine Sales by Geographic Area in 2024
5.5.8 Walvax Biotechnology Recent Developments
5.6 Minhai Biotechnology
5.6.1 Minhai Biotechnology Company Information
5.6.2 Minhai Biotechnology Description, Business Overview
5.6.3 Minhai Biotechnology Pertussis Vaccine Products Offered
5.6.4 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Minhai Biotechnology Pertussis Vaccine Sales by Product in 2024
5.6.6 Minhai Biotechnology Pertussis Vaccine Sales by Application in 2024
5.6.7 Minhai Biotechnology Pertussis Vaccine Sales by Geographic Area in 2024
5.6.8 Minhai Biotechnology Recent Developments
5.7 KM Biologics
5.7.1 KM Biologics Company Information
5.7.2 KM Biologics Description, Business Overview
5.7.3 KM Biologics Pertussis Vaccine Products Offered
5.7.4 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 KM Biologics Pertussis Vaccine Sales by Product in 2024
5.7.6 KM Biologics Pertussis Vaccine Sales by Application in 2024
5.7.7 KM Biologics Pertussis Vaccine Sales by Geographic Area in 2024
5.7.8 KM Biologics Recent Developments
5.8 Chengdu Institute of Biological Products
5.8.1 Chengdu Institute of Biological Products Company Information
5.8.2 Chengdu Institute of Biological Products Description, Business Overview
5.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Products Offered
5.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Chengdu Institute of Biological Products Pertussis Vaccine Sales by Product in 2024
5.8.6 Chengdu Institute of Biological Products Pertussis Vaccine Sales by Application in 2024
5.8.7 Chengdu Institute of Biological Products Pertussis Vaccine Sales by Geographic Area in 2024
5.8.8 Chengdu Institute of Biological Products Recent Developments
6 North America
6.1 North America Pertussis Vaccine Market Size YoY Growth 2020-2031
6.2 North America Pertussis Vaccine Market Facts & Figures by Country
6.2.1 North America Pertussis Vaccine Sales by Country (2020-2031)
6.2.2 North America Pertussis Vaccine Revenue by Country (2020-2031)
6.3 North America Pertussis Vaccine Sales by Type (2020-2025)
6.4 North America Pertussis Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Pertussis Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Pertussis Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Pertussis Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Pertussis Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Pertussis Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Pertussis Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe Pertussis Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Pertussis Vaccine Market Facts & Figures by Country
8.2.1 Europe Pertussis Vaccine Sales by Country (2020-2031)
8.2.2 Europe Pertussis Vaccine Revenue by Country (2020-2031)
8.3 Europe Pertussis Vaccine Sales by Type (2020-2025)
8.4 Europe Pertussis Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Pertussis Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Pertussis Vaccine Market Facts & Figures by Country
9.2.1 Latin America Pertussis Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Pertussis Vaccine Revenue by Country (2020-2031)
9.3 Latin America Pertussis Vaccine Sales by Type (2020-2025)
9.4 Latin America Pertussis Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Pertussis Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Pertussis Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Pertussis Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Pertussis Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Pertussis Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Pertussis Vaccine Supply Chain Analysis
11.2 Pertussis Vaccine Key Raw Materials and Upstream Suppliers
11.3 Pertussis Vaccine Clients Analysis
11.4 Pertussis Vaccine Sales Channel and Sales Model Analysis
11.4.1 Pertussis Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Pertussis Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Pertussis Vaccine Distributors
12 Pertussis Vaccine Market Dynamics
12.1 Pertussis Vaccine Industry Trends
12.2 Pertussis Vaccine Market Drivers
12.3 Pertussis Vaccine Market Challenges
12.4 Pertussis Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Pertussis Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Pertussis Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Pertussis Vaccine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Pertussis Vaccine Sales by Region (2020-2025) & (M Doses)
Table 5. Global Pertussis Vaccine Sales Forecast by Region (2026-2031) & (M Doses)
Table 6. Global Pertussis Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Pertussis Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Pertussis Vaccine Sales Volume by Type (2020-2025) & (M Doses)
Table 9. Global Pertussis Vaccine Sales Volume by Type (2026-2031) & (M Doses)
Table 10. Global Pertussis Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Pertussis Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Pertussis Vaccine Sales Volume by Application (2020-2025) & (M Doses)
Table 13. Global Pertussis Vaccine Sales Volume by Application (2026-2031) & (M Doses)
Table 14. Global Pertussis Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Pertussis Vaccine Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Pertussis Vaccine Sales by Manufacturer (2020-2025) & (M Doses)
Table 17. Global Pertussis Vaccine Sales Share by Manufacturer (2020-2025)
Table 18. Pertussis Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Pertussis Vaccine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Pertussis Vaccine Price (2020-2025) & (USD/Doses)
Table 21. Ranking of Global Top Pertussis Vaccine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Pertussis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2024)
Table 24. Pertussis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Pertussis Vaccine Market
Table 26. Manufacturers Pertussis Vaccine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Sanofi Pasteur Company Information
Table 29. Sanofi Pasteur Description and Business Overview
Table 30. Sanofi Pasteur Pertussis Vaccine Product
Table 31. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 32. Sanofi Pasteur Sales Proportion of Pertussis Vaccine by Product in 2024
Table 33. Sanofi Pasteur Sales Proportion of Pertussis Vaccine by Application in 2024
Table 34. Sanofi Pasteur Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 35. Sanofi Pasteur Recent Developments
Table 36. GSK Company Information
Table 37. GSK Description and Business Overview
Table 38. GSK Pertussis Vaccine Product
Table 39. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 40. GSK Sales Proportion of Pertussis Vaccine by Product in 2024
Table 41. GSK Sales Proportion of Pertussis Vaccine by Application in 2024
Table 42. GSK Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 43. GSK Recent Developments
Table 44. Mitsubishi Tanabe Pharma Company Information
Table 45. Mitsubishi Tanabe Pharma Description and Business Overview
Table 46. Mitsubishi Tanabe Pharma Pertussis Vaccine Product
Table 47. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 48. Mitsubishi Tanabe Pharma Sales Proportion of Pertussis Vaccine by Product in 2024
Table 49. Mitsubishi Tanabe Pharma Sales Proportion of Pertussis Vaccine by Application in 2024
Table 50. Mitsubishi Tanabe Pharma Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 51. Mitsubishi Tanabe Pharma Recent Developments
Table 52. Wuhan Institute of Biological Products Company Information
Table 53. Wuhan Institute of Biological Products Description and Business Overview
Table 54. Wuhan Institute of Biological Products Pertussis Vaccine Product
Table 55. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 56. Wuhan Institute of Biological Products Sales Proportion of Pertussis Vaccine by Product in 2024
Table 57. Wuhan Institute of Biological Products Sales Proportion of Pertussis Vaccine by Application in 2024
Table 58. Wuhan Institute of Biological Products Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 59. Wuhan Institute of Biological Products Recent Developments
Table 60. Walvax Biotechnology Company Information
Table 61. Walvax Biotechnology Description and Business Overview
Table 62. Walvax Biotechnology Pertussis Vaccine Product
Table 63. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 64. Walvax Biotechnology Sales Proportion of Pertussis Vaccine by Product in 2024
Table 65. Walvax Biotechnology Sales Proportion of Pertussis Vaccine by Application in 2024
Table 66. Walvax Biotechnology Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 67. Walvax Biotechnology Recent Developments
Table 68. Minhai Biotechnology Company Information
Table 69. Minhai Biotechnology Description and Business Overview
Table 70. Minhai Biotechnology Pertussis Vaccine Product
Table 71. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 72. Minhai Biotechnology Sales Proportion of Pertussis Vaccine by Product in 2024
Table 73. Minhai Biotechnology Sales Proportion of Pertussis Vaccine by Application in 2024
Table 74. Minhai Biotechnology Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 75. Minhai Biotechnology Recent Developments
Table 76. KM Biologics Company Information
Table 77. KM Biologics Description and Business Overview
Table 78. KM Biologics Pertussis Vaccine Product
Table 79. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 80. KM Biologics Sales Proportion of Pertussis Vaccine by Product in 2024
Table 81. KM Biologics Sales Proportion of Pertussis Vaccine by Application in 2024
Table 82. KM Biologics Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 83. KM Biologics Recent Developments
Table 84. Chengdu Institute of Biological Products Company Information
Table 85. Chengdu Institute of Biological Products Description and Business Overview
Table 86. Chengdu Institute of Biological Products Pertussis Vaccine Product
Table 87. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 88. Chengdu Institute of Biological Products Sales Proportion of Pertussis Vaccine by Product in 2024
Table 89. Chengdu Institute of Biological Products Sales Proportion of Pertussis Vaccine by Application in 2024
Table 90. Chengdu Institute of Biological Products Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 91. Chengdu Institute of Biological Products Recent Developments
Table 92. North America Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 93. North America Pertussis Vaccine Sales by Country (2026-2031) & (M Doses)
Table 94. North America Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 95. North America Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 96. North America Pertussis Vaccine Sales by Type (2020-2025) & (M Doses)
Table 97. North America Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 98. Asia-Pacific Pertussis Vaccine Sales by Region (2020-2025) & (M Doses)
Table 99. Asia-Pacific Pertussis Vaccine Sales by Region (2026-2031) & (M Doses)
Table 100. Asia-Pacific Pertussis Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 101. Asia-Pacific Pertussis Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 102. Asia-Pacific Pertussis Vaccine Sales by Type (2020-2025) & (M Doses)
Table 103. Asia-Pacific Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 104. Europe Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 105. Europe Pertussis Vaccine Sales by Country (2026-2031) & (M Doses)
Table 106. Europe Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 107. Europe Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 108. Europe Pertussis Vaccine Sales by Type (2020-2025) & (M Doses)
Table 109. Europe Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 110. Latin America Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 111. Latin America Pertussis Vaccine Sales by Country (2026-2031) & (M Doses)
Table 112. Latin America Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 113. Latin America Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 114. Latin America Pertussis Vaccine Sales by Type (2020-2025) & (M Doses)
Table 115. Latin America Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 116. Middle East and Africa Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 117. Middle East and Africa Pertussis Vaccine Sales by Country (2026-2031) & (M Doses)
Table 118. Middle East and Africa Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 119. Middle East and Africa Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 120. Middle East and Africa Pertussis Vaccine Sales by Type (2020-2025) & (M Doses)
Table 121. Middle East and Africa Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 122. Pertussis Vaccine Key Raw Materials, Industry Status and Trend
Table 123. Pertussis Vaccine Key Raw Materials and Upstream Suppliers
Table 124. Pertussis Vaccine Clients Status and Trend
Table 125. Pertussis Vaccine Typical Clients
Table 126. Pertussis Vaccine Distributors
Table 127. Pertussis Vaccine Market Trends
Table 128. Pertussis Vaccine Market Drivers
Table 129. Pertussis Vaccine Market Challenges
Table 130. Pertussis Vaccine Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Pertussis Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Whole-cell Vaccines Product Picture
Figure 5. Acellular Vaccines Product Picture
Figure 6. Global Pertussis Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Pertussis Vaccine Sales Market Share by Application in 2024 & 2031
Figure 8. 12 Months Below
Figure 9. 12 Months Above
Figure 10. Pertussis Vaccine Report Years Considered
Figure 11. Global Pertussis Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Pertussis Vaccine Market Size 2020-2031 (US$ Million)
Figure 13. Global Pertussis Vaccine Sales 2020-2031 (M Doses)
Figure 14. Global Pertussis Vaccine Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Pertussis Vaccine Revenue Market Share by Region (2020-2031)
Figure 16. Global Pertussis Vaccine Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Pertussis Vaccine Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Pertussis Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Doses)
Figure 19. Global Pertussis Vaccine Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Pertussis Vaccine Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Pertussis Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/Doses)
Figure 22. Whole-cell Vaccines of Pertussis Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 23. Acellular Vaccines of Pertussis Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Pertussis Vaccine Sales Share by Manufacturer in 2024
Figure 25. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Whole-cell Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 27. Acellular Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Pertussis Vaccine Revenue 2020-2031 (US$ Million)
Figure 29. North America Pertussis Vaccine Sales Market Share by Type (2020-2025)
Figure 30. North America Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Pertussis Vaccine Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Pertussis Vaccine Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Pertussis Vaccine Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Pertussis Vaccine Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 36. Europe Pertussis Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Pertussis Vaccine Sales Market Share by Country (2020-2031)
Figure 38. Europe Pertussis Vaccine Revenue Market Share by Country (2020-2031)
Figure 39. Europe Pertussis Vaccine Sales Market Share by Type (2020-2025)
Figure 40. Europe Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 41. Latin America Pertussis Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Pertussis Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Pertussis Vaccine Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Pertussis Vaccine Sales Market Share by Type (2020-2025)
Figure 45. Latin America Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Pertussis Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Pertussis Vaccine Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 51. Pertussis Vaccine Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Pertussis Vaccine Raw Materials by Region in 2024
Figure 53. Pertussis Vaccine Distribution Channels
Figure 54. Global Pertussis Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Pertussis Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Pertussis Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Pertussis Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Pertussis Vaccine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Pertussis Vaccine Sales by Region (2020-2025) & (M Doses)
Table 5. Global Pertussis Vaccine Sales Forecast by Region (2026-2031) & (M Doses)
Table 6. Global Pertussis Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Pertussis Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Pertussis Vaccine Sales Volume by Type (2020-2025) & (M Doses)
Table 9. Global Pertussis Vaccine Sales Volume by Type (2026-2031) & (M Doses)
Table 10. Global Pertussis Vaccine Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Pertussis Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Pertussis Vaccine Sales Volume by Application (2020-2025) & (M Doses)
Table 13. Global Pertussis Vaccine Sales Volume by Application (2026-2031) & (M Doses)
Table 14. Global Pertussis Vaccine Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Pertussis Vaccine Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Pertussis Vaccine Sales by Manufacturer (2020-2025) & (M Doses)
Table 17. Global Pertussis Vaccine Sales Share by Manufacturer (2020-2025)
Table 18. Pertussis Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Pertussis Vaccine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Pertussis Vaccine Price (2020-2025) & (USD/Doses)
Table 21. Ranking of Global Top Pertussis Vaccine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Pertussis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Pertussis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pertussis Vaccine as of 2024)
Table 24. Pertussis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Pertussis Vaccine Market
Table 26. Manufacturers Pertussis Vaccine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Sanofi Pasteur Company Information
Table 29. Sanofi Pasteur Description and Business Overview
Table 30. Sanofi Pasteur Pertussis Vaccine Product
Table 31. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 32. Sanofi Pasteur Sales Proportion of Pertussis Vaccine by Product in 2024
Table 33. Sanofi Pasteur Sales Proportion of Pertussis Vaccine by Application in 2024
Table 34. Sanofi Pasteur Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 35. Sanofi Pasteur Recent Developments
Table 36. GSK Company Information
Table 37. GSK Description and Business Overview
Table 38. GSK Pertussis Vaccine Product
Table 39. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 40. GSK Sales Proportion of Pertussis Vaccine by Product in 2024
Table 41. GSK Sales Proportion of Pertussis Vaccine by Application in 2024
Table 42. GSK Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 43. GSK Recent Developments
Table 44. Mitsubishi Tanabe Pharma Company Information
Table 45. Mitsubishi Tanabe Pharma Description and Business Overview
Table 46. Mitsubishi Tanabe Pharma Pertussis Vaccine Product
Table 47. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 48. Mitsubishi Tanabe Pharma Sales Proportion of Pertussis Vaccine by Product in 2024
Table 49. Mitsubishi Tanabe Pharma Sales Proportion of Pertussis Vaccine by Application in 2024
Table 50. Mitsubishi Tanabe Pharma Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 51. Mitsubishi Tanabe Pharma Recent Developments
Table 52. Wuhan Institute of Biological Products Company Information
Table 53. Wuhan Institute of Biological Products Description and Business Overview
Table 54. Wuhan Institute of Biological Products Pertussis Vaccine Product
Table 55. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 56. Wuhan Institute of Biological Products Sales Proportion of Pertussis Vaccine by Product in 2024
Table 57. Wuhan Institute of Biological Products Sales Proportion of Pertussis Vaccine by Application in 2024
Table 58. Wuhan Institute of Biological Products Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 59. Wuhan Institute of Biological Products Recent Developments
Table 60. Walvax Biotechnology Company Information
Table 61. Walvax Biotechnology Description and Business Overview
Table 62. Walvax Biotechnology Pertussis Vaccine Product
Table 63. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 64. Walvax Biotechnology Sales Proportion of Pertussis Vaccine by Product in 2024
Table 65. Walvax Biotechnology Sales Proportion of Pertussis Vaccine by Application in 2024
Table 66. Walvax Biotechnology Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 67. Walvax Biotechnology Recent Developments
Table 68. Minhai Biotechnology Company Information
Table 69. Minhai Biotechnology Description and Business Overview
Table 70. Minhai Biotechnology Pertussis Vaccine Product
Table 71. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 72. Minhai Biotechnology Sales Proportion of Pertussis Vaccine by Product in 2024
Table 73. Minhai Biotechnology Sales Proportion of Pertussis Vaccine by Application in 2024
Table 74. Minhai Biotechnology Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 75. Minhai Biotechnology Recent Developments
Table 76. KM Biologics Company Information
Table 77. KM Biologics Description and Business Overview
Table 78. KM Biologics Pertussis Vaccine Product
Table 79. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 80. KM Biologics Sales Proportion of Pertussis Vaccine by Product in 2024
Table 81. KM Biologics Sales Proportion of Pertussis Vaccine by Application in 2024
Table 82. KM Biologics Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 83. KM Biologics Recent Developments
Table 84. Chengdu Institute of Biological Products Company Information
Table 85. Chengdu Institute of Biological Products Description and Business Overview
Table 86. Chengdu Institute of Biological Products Pertussis Vaccine Product
Table 87. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 88. Chengdu Institute of Biological Products Sales Proportion of Pertussis Vaccine by Product in 2024
Table 89. Chengdu Institute of Biological Products Sales Proportion of Pertussis Vaccine by Application in 2024
Table 90. Chengdu Institute of Biological Products Sales Proportion of Pertussis Vaccine by Geographic Area in 2024
Table 91. Chengdu Institute of Biological Products Recent Developments
Table 92. North America Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 93. North America Pertussis Vaccine Sales by Country (2026-2031) & (M Doses)
Table 94. North America Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 95. North America Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 96. North America Pertussis Vaccine Sales by Type (2020-2025) & (M Doses)
Table 97. North America Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 98. Asia-Pacific Pertussis Vaccine Sales by Region (2020-2025) & (M Doses)
Table 99. Asia-Pacific Pertussis Vaccine Sales by Region (2026-2031) & (M Doses)
Table 100. Asia-Pacific Pertussis Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 101. Asia-Pacific Pertussis Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 102. Asia-Pacific Pertussis Vaccine Sales by Type (2020-2025) & (M Doses)
Table 103. Asia-Pacific Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 104. Europe Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 105. Europe Pertussis Vaccine Sales by Country (2026-2031) & (M Doses)
Table 106. Europe Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 107. Europe Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 108. Europe Pertussis Vaccine Sales by Type (2020-2025) & (M Doses)
Table 109. Europe Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 110. Latin America Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 111. Latin America Pertussis Vaccine Sales by Country (2026-2031) & (M Doses)
Table 112. Latin America Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 113. Latin America Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 114. Latin America Pertussis Vaccine Sales by Type (2020-2025) & (M Doses)
Table 115. Latin America Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 116. Middle East and Africa Pertussis Vaccine Sales by Country (2020-2025) & (M Doses)
Table 117. Middle East and Africa Pertussis Vaccine Sales by Country (2026-2031) & (M Doses)
Table 118. Middle East and Africa Pertussis Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 119. Middle East and Africa Pertussis Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 120. Middle East and Africa Pertussis Vaccine Sales by Type (2020-2025) & (M Doses)
Table 121. Middle East and Africa Pertussis Vaccine Sales by Application (2020-2025) & (M Doses)
Table 122. Pertussis Vaccine Key Raw Materials, Industry Status and Trend
Table 123. Pertussis Vaccine Key Raw Materials and Upstream Suppliers
Table 124. Pertussis Vaccine Clients Status and Trend
Table 125. Pertussis Vaccine Typical Clients
Table 126. Pertussis Vaccine Distributors
Table 127. Pertussis Vaccine Market Trends
Table 128. Pertussis Vaccine Market Drivers
Table 129. Pertussis Vaccine Market Challenges
Table 130. Pertussis Vaccine Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Pertussis Vaccine Product Picture
Figure 2. Global Pertussis Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Pertussis Vaccine Sales Market Share by Type in 2024 & 2031
Figure 4. Whole-cell Vaccines Product Picture
Figure 5. Acellular Vaccines Product Picture
Figure 6. Global Pertussis Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Pertussis Vaccine Sales Market Share by Application in 2024 & 2031
Figure 8. 12 Months Below
Figure 9. 12 Months Above
Figure 10. Pertussis Vaccine Report Years Considered
Figure 11. Global Pertussis Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Pertussis Vaccine Market Size 2020-2031 (US$ Million)
Figure 13. Global Pertussis Vaccine Sales 2020-2031 (M Doses)
Figure 14. Global Pertussis Vaccine Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Pertussis Vaccine Revenue Market Share by Region (2020-2031)
Figure 16. Global Pertussis Vaccine Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Pertussis Vaccine Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Pertussis Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Doses)
Figure 19. Global Pertussis Vaccine Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Pertussis Vaccine Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Pertussis Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/Doses)
Figure 22. Whole-cell Vaccines of Pertussis Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 23. Acellular Vaccines of Pertussis Vaccine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Pertussis Vaccine Sales Share by Manufacturer in 2024
Figure 25. Pertussis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Whole-cell Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 27. Acellular Vaccines Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Pertussis Vaccine Revenue 2020-2031 (US$ Million)
Figure 29. North America Pertussis Vaccine Sales Market Share by Type (2020-2025)
Figure 30. North America Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Pertussis Vaccine Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Pertussis Vaccine Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Pertussis Vaccine Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Pertussis Vaccine Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 36. Europe Pertussis Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Pertussis Vaccine Sales Market Share by Country (2020-2031)
Figure 38. Europe Pertussis Vaccine Revenue Market Share by Country (2020-2031)
Figure 39. Europe Pertussis Vaccine Sales Market Share by Type (2020-2025)
Figure 40. Europe Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 41. Latin America Pertussis Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Pertussis Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Pertussis Vaccine Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Pertussis Vaccine Sales Market Share by Type (2020-2025)
Figure 45. Latin America Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Pertussis Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Pertussis Vaccine Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Pertussis Vaccine Sales Market Share by Application (2020-2025)
Figure 51. Pertussis Vaccine Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Pertussis Vaccine Raw Materials by Region in 2024
Figure 53. Pertussis Vaccine Distribution Channels
Figure 54. Global Pertussis Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Pertussis Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232